RxDoctor Payments Data

Catherine Mercer

Adult Health · Sallisaw, OKNPI 1902037252

Payments from drug & device makers

$239in general payments, 2019–2025

Across 13 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$83
  • Amgen$31
  • Abbott$24
  • Lilly USA, LLC$20
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$18
  • Boehringer Ingelheim$17
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$239 in reported general payments places this provider in the 35th percentile of 117 adult health providers in Oklahoma.

See all adult health providers in Oklahoma

Medicare billing

Part B allowed, 2024
$63,299
Medicare patients
272
Services billed
1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate28$37,938
OzempicSemaglutide17$36,093
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$23,797
JardianceEmpagliflozin14$15,801
MounjaroTirzepatide11$13,975
MyrbetriqMirabegron13$12,366
SymbicortBudesonide/Formoterol Fumarate14$3,863
Sucralfate25$2,700
Albuterol Sulfate HfaAlbuterol Sulfate103$2,672
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,490
Omeprazole71$1,600
Duloxetine Hcl56$1,343
Atorvastatin Calcium108$1,173
Gabapentin88$1,096
Dicyclomine Hcl44$941

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$36,09317 claims
GSKTrelegy Ellipta$14$23,79726 claims
Boehringer IngelheimJardiance$17$15,80114 claims
Lilly USA, LLCMounjaro$20$13,97511 claims
AstraZenecaSymbicort$83$3,86314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 117 adult health providers in Oklahoma.

Other adult health in Sallisaw

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →